Related Experiment Video
Updated: Jun 8, 2026
05:59
An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
Published on: November 4, 2022
On variability in test results of current in vitro dissolution tests
1BioKinet Inc, PO Box 269035, Indianapolis, Indiana 46226-9035, USA. ZengWB@sbcglobal.net
Journal of Pharmaceutical Sciences
|September 23, 2010
Summary
Variability in in vitro dissolution testing results can stem from initial product delays, not dissolution rate differences. This suggests high variability in dissolution tests may not reflect true clinical significance.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery
- Physical Chemistry
Background:
- Current in vitro dissolution tests exhibit variability.
- Understanding the sources of this variability is crucial for accurate drug product assessment.
Purpose of the Study:
- To analyze theoretical cumulative mass dissolved-time profile curves using Weibull distributions.
- To illustrate the dependency of in vitro dissolution test variability on curve slope and time-shift.
Main Methods:
- Utilized Weibull distributions to model theoretical dissolution profile curves.
- Analyzed the relationship between curve parameters (slope, time-shift) and result variability.
Main Results:
- Variability in dissolution test results is dependent on the slope of the dissolution profile curve and the cumulative time-shift.
- High observed variability may disproportionately reflect initial dissolution delays (e.g., coating dissolution, wetting) rather than intrinsic dissolution rate variations.
Conclusions:
- High variability in in vitro dissolution testing may not be clinically significant.
- The analysis provides a framework for re-interpreting dissolution test variability, distinguishing between initial process delays and true dissolution rate differences.
Related Concept Videos
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:17In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
01:20Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...